CD274 and neoplasm: In all, 32 (43.2%), 22 (29.8%), 10 (13.5%), and 10 (13.5%) patients had tumor PD-L1 expression of >50%, tumor PD-L1 expression between 1% and 50%, tumor PD-L1 expression of <1%, and unknown PD-L1 status, respectively.